tDCS (Transcranial Direct Current Stimulation) — Cognitive Technologies & Brain Longevity
Non-invasive constant low-amperage brain stimulation through scalp electrodes — modulates cortical excitability for cognitive enhancement, motor learning, depression, and pain.
Overview
Transcranial Direct Current Stimulation (tDCS) delivers a weak constant direct current (1-2 mA) through scalp electrodes, modulating neuronal membrane potentials without directly triggering action potentials. Anodal stimulation (positive electrode, anode) increases cortical excitability; cathodal stimulation decreases it. Effects persist 30-90 minutes post-stimulation through NMDA receptor-dependent mechanisms. A 2020 meta-analysis of 100+ RCTs found tDCS over the left dorsolateral prefrontal cortex (DLPFC) improves working memory with small-to-moderate effect sizes, and over the motor cortex improves motor learning in healthy individuals. A 2019 meta-analysis found significant antidepressant effects comparable to pharmacotherapy for major depression. The SELECT-TDCS trial (n=236, published 2023) failed to show superiority over sham for MDD — highlighting the research-to-clinical translation challenge. tDCS is among the most studied non-invasive neurostimulation technologies, with 50,000+ published papers. Home-use devices (Soterix, Stimlabs, Flow Neuroscience) have made it widely accessible but raise safety and efficacy concerns without clinical supervision.
Indications
- Major depression (evidence for 2 mA, 20 min, left-anodal DLPFC protocol)
- Cognitive performance and working memory enhancement (healthy individuals)
- Motor skill learning and rehabilitation
- Chronic pain (motor cortex stimulation)
- Stroke rehabilitation (motor cortex)
- PTSD and anxiety (prefrontal anodal)
Mechanism of Action
Subthreshold direct current shifts neuronal resting membrane potential — anodal current brings membranes closer to firing threshold (depolarization), increasing excitability; cathodal current hyperpolarizes, decreasing excitability
Dosing
| Compound | Dose | Frequency | Notes |
|---|---|---|---|
| tDCS (anodal left DLPFC for cognition/depression) | 2 mA for 20 minutes | Daily for 5-10 consecutive days (acute series); 2-3x/week maintenance | Left DLPFC (F3) anode is most validated placement for both cognition enhancement and depression; home devices available ($400-800) |
| tDCS (motor cortex for skill learning) | 1-2 mA for 20 minutes | During or immediately before motor practice sessions | Anodal M1 stimulation enhances motor cortex excitability and facilitates motor learning and rehabilitation |
Evidence Grade
GRADE B
Safety & Contraindications
- Generally safe at 1-2 mA for ≤ 20 min; FDA guidance suggests ≤ 2 mA and ≤ 20 min as safe boundaries
- Skin irritation and tingling under electrodes — use proper saline-soaked sponge electrodes or conductive gel
- Do not increase beyond 2 mA without clinical supervision — higher currents risk skin burns
- Contraindications: metallic implants in/near head (aneurysm clips, cochlear implants), unstable epilepsy, pregnancy
- Long-term effects of chronic repeated stimulation not fully established
- Home-use without clinical guidance (for medical indications) is not recommended
- Electrode placement errors can produce unintended effects — cathodal placement over temporal lobe can worsen mood